CompletedNCT01312272
Does Acute Oxytocin Administration Enhance Social Cognition in Individuals With Schizophrenia?
This study has finished and is no longer accepting participants.
In Los AngelesSchizophreniaMedication studyAges 18–55
Schizophrenia studies
Schizophrenia
Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
UnknownNCT04892199
Does GLP-1RA Prevent Deterioration of Metabolic State in Prediabetic and Diabetic Patients Treated With Antipsychotic Medication?
Official study title
Does the Glucagon-like Peptide-1 Receptor Agonist Semaglutide Prevent Deterioration of Metabolic State in Prediabetic or Diabetic Patients With Schizophrenia Treated With the Antipsychotic Compounds Clozapine or Olanzapine?
Current recruitment status is unconfirmed.
Multiple locations, including AarhusSchizophreniaMedication studyAges 18–65
CompletedNCT01035996
Dopamine Function and Reward Processing In Schizophrenia
This study has finished and is no longer accepting participants.
In BaltimoreSchizophreniaObservational studyAges 18–50
CompletedNCT01041092
Double Blind, Study of Raloxifene for Negative Symptoms of Schizophrenia in Postmenopausal Women
What is this study about?
This study evaluated the safety and effectiveness of raloxifene for people with schizophrenia.
This study has finished and is no longer accepting participants.
In Esplugues de LlobregatSchizophreniaMedication studyAges 40+
TerminatedNCT00570063
Double Blind, 3 Week Inpatient Study Safety & Efficacy Of PF-02545920 Compared With Placebo
What is this study about?
This study evaluates the safety and effectiveness of PF-02545920 for people with schizophrenia.
This study ended early.
Multiple locations, including GlendaleSchizophreniaPlacebo comparisonAges 18–99
CompletedNCT01338298
Placebo Controlled Study of Adjunctive Aripiprazole for Symptomatic Hyperprolactinemia In Premenopausal Women With Schizophrenia
Official study title
Double-Blind Placebo Controlled Study of Adjunctive Aripiprazole for Symptomatic Hyperprolactinemia In Premenopausal Women With Schizophrenia
This study has finished and is no longer accepting participants.
In CatonsvilleSchizophreniaMedication studyAges 18–50
CompletedNCT00783185
Cannabis reduction and social skills training for psychosis
About this title
Dual Diagnosis (Psychosis and Cannabismisuse): Comparison of Specialized Treatment Versus Unspecified Treatment
Read the official source — NCT00783185Official study title
Dual Diagnosis Psychosis and Substance Abuse: Short- and Middle-term Changes in Symptomatology After Visiting a Group Education Programme to Reduce Consumption of Cannabis
This study has finished and is no longer accepting participants.
In KonstanzSchizophreniaBehavioural studyAges 18–65
CompletedNCT02918630
E-cigarettes to Promote Smoking Reduction Among Individuals With Schizophrenia
This study has finished and is no longer accepting participants.
In HoustonSchizophreniaMedication studyAges 18–65
CompletedNCT00204061
Amisulpride with supportive care for late early-warning signs of psychosis
About this title
Early Pharmacological and Psychological Intervention for Late Prodromal States of Psychosis
Read the official source — NCT00204061Official study title
Early Pharmacological and Psychological Intervention for Late Prodromal States of Psychosis
This study has finished and is no longer accepting participants.
In CologneSchizophreniaMedication studyAges 14–36
CompletedNCT03730857
Early Predictors of Poor Treatment Response in people with Schizophrenia Treated With Atypical Antipsychotics
Official study title
Early Predictors of Poor Treatment Response in Patients With Schizophrenia Treated With Atypical Antipsychotics
This study has finished and is no longer accepting participants.
Location not clearly listedSchizophreniaMedication studyAges 18–65
TerminatedNCT03852706
EEG-based Neurofeedback for Auditory Verbal Hallucinations (HALFEED)
Official study title
A Randomized Controlled Pilot Trial of Low-resolution Brain Electromagnetic Tomography (LORETA) Neurofeedback Training for Treatment-resistant Auditory Verbal Hallucinations in Schizophrenia
This study ended early.
In DublinSchizophreniaInterventional studyAges 18+
UnknownNCT06505668
Effect of Atenolol Versus Ivabradine on HRV in TRS Patients on Clozapine With Tachycardia: A Control study.
Official study title
Effect Of Atenolol Versus Ivabradine On Heart Rate Variability In Treatment Resistant Schizophrenia Patients On Clozapine With Tachycardia: A Randomized Control Trial.
Current recruitment status is unconfirmed.
In BhubaneswarSchizophreniaMedication studyAges 18–60
Registry coverage
We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.